Welcome to
On Feet Nation
goditac499 Online
Dave Jack Online
Thomas Online
Tommy Online
JerryBerry Online
Micheal Jorden Online
Posted by Khalid Shaikh on August 31, 2024 at 8:16am 0 Comments 0 Likes
Posted by Selma on August 31, 2024 at 8:16am 0 Comments 0 Likes
Indian Pharma has not received any gifts yet
Posted on September 19, 2023 at 8:59am 0 Comments 0 Likes
When using trientine therapy to treat Wilson's disease, monitoring copper levels is crucial. Testing of the blood and urine is routinely performed on patients to keep tabs on their liver function and copper levels. The medical expert uses these test results to adjust the triennial dosage and ensure copper levels are acceptable. Continuous observation helps to maintain Trientine's therapeutic effects while minimizing copper accumulation and associated issues. Patients should show up for all…
ContinuePosted on September 13, 2023 at 8:29am 0 Comments 0 Likes
The FDA-approved medicine nitisinone is used to treat HT-1 (hereditary tyrosinemia). It is a reversible synthetic inhibitor of 4-hydroxyphenylpyruvate dioxygenase, an enzyme that generates toxic chemicals related to HT-1. Patients must follow a rigorous diet that limits their intake of tyrosine and phenylalanine in addition to taking Nitisinone. Any unexpected eye issues, rashes, jaundice, or significant bleeding should be reported immediately. Nitisinone dosage can be changed based on how…
ContinuePosted on August 10, 2023 at 8:30am 0 Comments 0 Likes
Treatment for HT-1 (hereditary tyrosinemia) involves using the FDA-approved medication nitisinone. It is a synthetic, reversible inhibitor of 4-hydroxyphenylpyruvate dioxygenase, an enzyme producing harmful compounds connected to HT-1. In addition to taking Nitisinone, patients must follow a strict diet restricting their intake of tyrosine and phenylalanine. Report any unexpected eye problems, rashes, jaundice, or substantial bleeding immediately. With a daily dose cap of 2 mg/kg, the dosage…
ContinuePosted on August 2, 2023 at 8:30am 0 Comments 0 Likes
A Managed Access Program (MAP) is a healthcare initiative designed to provide access to investigational or unapproved medications for patients with serious or life-threatening conditions. MAPs are developed in partnership with healthcare providers, regulatory bodies, and pharmaceutical companies. These programs address the urgent medical requirements of people who have exhausted all therapeutic…
Continue
© 2024 Created by PH the vintage.
Powered by
Comment Wall
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation